SSgA SPDR FTSE UK All Share UCITS ETF (LON:FTAL)
London · Delayed Price · Currency is GBP | Assets | 377.34M |
| Expense Ratio | 0.20% |
| PE Ratio | 13.94 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +20.80% |
| Volume | 3,512 |
| Open | 89.71 |
| Previous Close | 88.65 |
| Day's Range | 88.75 - 90.33 |
| 52-Week Low | 73.21 |
| 52-Week High | 92.74 |
| Beta | 0.99 |
| Holdings | 507 |
| Inception Date | Feb 28, 2012 |
About FTAL
SSgA SPDR FTSE UK All Share UCITS ETF is an exchange traded fund launched and managed by State Street Global Advisors Limited. The fund invests in the public equity markets of the United Kingdom. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the stocks of companies across all market capitalizations. It seeks to replicate the performance of the FTSE All-Share Index, by employing representative sampling methodology. The fund was formerly known as SSgA SPDR ETFs Europe I Public Limited Company - SPDR FTSE UK All Share ETF. SSgA SPDR FTSE UK All Share UCITS ETF was formed on February 28, 2012 and is domiciled in Ireland.
Performance
FTAL had a total return of 20.80% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.98%.
Top 10 Holdings
43.38% of assets| Name | Symbol | Weight |
|---|---|---|
| HSBC Holdings plc | HSBA | 8.45% |
| AstraZeneca PLC | AZN | 7.32% |
| Shell plc | SHEL | 6.28% |
| Rolls-Royce Holdings plc | RR | 4.01% |
| British American Tobacco p.l.c. | BATS | 3.42% |
| Unilever PLC | ULVR | 3.19% |
| Rio Tinto Group | RIO | 2.91% |
| BP p.l.c. | BP | 2.89% |
| GSK plc | GSK | 2.66% |
| Barclays PLC | BARC | 2.26% |